{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T04:43:41Z","timestamp":1792471421646,"version":"4.5.0"},"reference-count":169,"publisher":"Cold Spring Harbor Laboratory","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cold Spring Harb Perspect Med"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1101\/cshperspect.a030411","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T20:40:20Z","timestamp":1491597620000},"page":"a030411","source":"Crossref","is-referenced-by-count":180,"title":["Histopathology of Prostate Cancer"],"prefix":"10.1101","volume":"7","author":[{"given":"Peter A.","family":"Humphrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"246","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"key":"2018091410361216000_7.10.a030411.1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0046-8177(94)90268-2","article-title":"Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation. Report of 30 cases","volume":"25","year":"1994","journal-title":"Hum Pathol"},{"key":"2018091410361216000_7.10.a030411.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(94)80264-5"},{"key":"2018091410361216000_7.10.a030411.3","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000160980.62586.05"},{"key":"2018091410361216000_7.10.a030411.4","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000213395.42075.86"},{"key":"2018091410361216000_7.10.a030411.5","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2001.21135"},{"key":"2018091410361216000_7.10.a030411.6","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2001.21134"},{"key":"2018091410361216000_7.10.a030411.7","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/PAS.0000000000000205","article-title":"Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue","volume":"38","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"2018091410361216000_7.10.a030411.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2015.04.009"},{"key":"2018091410361216000_7.10.a030411.9","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199410000-00002"},{"key":"2018091410361216000_7.10.a030411.10","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199908000-00009"},{"key":"2018091410361216000_7.10.a030411.11","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/bjc.2016.86","article-title":"Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome","volume":"114","year":"2016","journal-title":"Br J Cancer"},{"key":"2018091410361216000_7.10.a030411.12","doi-asserted-by":"publisher","DOI":"10.1002\/pros.21154"},{"key":"2018091410361216000_7.10.a030411.13","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.humpath.2015.05.002","article-title":"A subset of prostatic basal cell carcinomas harbor the MYB rearrangement of adenoid cystic carcinoma","volume":"46","year":"2015","journal-title":"Hum Pathol"},{"key":"2018091410361216000_7.10.a030411.14","first-page":"432","article-title":"Multiple measures of carcinoma extent versus perineural invasion in prostate biopsy tissue in prediction of pathologic stage in a screening population","volume":"27","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"2018091410361216000_7.10.a030411.15","first-page":"807","article-title":"Histologic findings in postcryosurgical biopsies","volume":"9","year":"1996","journal-title":"Mod Pathol"},{"key":"2018091410361216000_7.10.a030411.16","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/00000478-199408000-00006","article-title":"Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies","volume":"18","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"2018091410361216000_7.10.a030411.17","first-page":"444","article-title":"Collagenous micronodules in prostate cancer. A specific but infrequent diagnostic finding","volume":"119","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"2018091410361216000_7.10.a030411.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2011.11.005"},{"key":"2018091410361216000_7.10.a030411.19","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197207)30:1<5::AID-CNCR2820300103>3.0.CO;2-S"},{"key":"2018091410361216000_7.10.a030411.20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.7759"},{"key":"2018091410361216000_7.10.a030411.21","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199910000-00002"},{"key":"2018091410361216000_7.10.a030411.22","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23004"},{"key":"2018091410361216000_7.10.a030411.23","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<703::AID-CNCR13>3.0.CO;2-1"},{"key":"2018091410361216000_7.10.a030411.24","unstructured":"Cheville J , Algaba F , Epstein JI , Lopez-Beltran A . 2016. Mesenchymal tumours. In WHO classification of tumours of the urinary system and male genital organs (ed. Moch H , ), pp. 175\u2013177. IARC, Lyon, France."},{"key":"2018091410361216000_7.10.a030411.25","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/PAS.0000000000000691","article-title":"Prognostic significance of percentage and architectural types of contemporary Gleason pattern 4 prostate cancer in radical prostatectomy","volume":"40","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"2018091410361216000_7.10.a030411.26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/modpathol.3800250","article-title":"Corpora amylacea in adenocarcinoma of the prostate: Incidence and histology within needle core biopsies","volume":"18","year":"2005","journal-title":"Mod Pathol"},{"key":"2018091410361216000_7.10.a030411.27","first-page":"287","article-title":"Adenocarcinoma of the prostate with atrophic features","volume":"21","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"2018091410361216000_7.10.a030411.28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.juro.2016.01.120","article-title":"Prognostic value of percent Gleason grade 4 at prostate biopsy on predicting prostatectomy pathology and recurrence","volume":"196","year":"2016","journal-title":"J Urol"},{"key":"2018091410361216000_7.10.a030411.29","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24020"},{"key":"2018091410361216000_7.10.a030411.30","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/PAT.0000000000000318","article-title":"Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 \u201cRADAR\u201d trial clinical data","volume":"47","year":"2015","journal-title":"Pathology"},{"key":"2018091410361216000_7.10.a030411.31","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3349\/ymj.2016.57.5.1054","article-title":"Intraductal carcinoma of the prostate gland: Recent advances","volume":"57","year":"2016","journal-title":"Yonsei Med J"},{"key":"2018091410361216000_7.10.a030411.32","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197308)32:2<402::AID-CNCR2820320218>3.0.CO;2-Q"},{"key":"2018091410361216000_7.10.a030411.33","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950915)76:6<1035::AID-CNCR2820760618>3.0.CO;2-8"},{"key":"2018091410361216000_7.10.a030411.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.10.020"},{"key":"2018091410361216000_7.10.a030411.35","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199708000-00007"},{"key":"2018091410361216000_7.10.a030411.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64669-1"},{"key":"2018091410361216000_7.10.a030411.37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.eururo.2015.11.008","article-title":"Utility of reporting the percentage of high-grade cancer","volume":"69","year":"2016","journal-title":"Eur Urol"},{"key":"2018091410361216000_7.10.a030411.38","unstructured":"Egevad L , Epstein JI , Hameed O , Humphrey PA , Samaratunga H . 2016b. Ductal adenocarcinoma. In WHO classification of tumours of the urinary system and male genital organs (ed. Moch H, ), pp. 166\u2013167. IARC, Lyon, France."},{"key":"2018091410361216000_7.10.a030411.39","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(95)90041-1"},{"key":"2018091410361216000_7.10.a030411.40","first-page":"443","article-title":"An update of the Gleason grading system","volume":"183","year":"2010","journal-title":"J Urol"},{"key":"2018091410361216000_7.10.a030411.41","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000173646.99337.b1"},{"key":"2018091410361216000_7.10.a030411.42","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000208"},{"key":"2018091410361216000_7.10.a030411.43","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/PAS.0000000000000238","article-title":"Best practices recommendations in the application of immunohistochemistry in the prostate: Report from the International Society of Urologic Pathology Consensus Conference","volume":"38","author":"Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"2018091410361216000_7.10.a030411.44","unstructured":"Epstein JI , Amin MB , Evans AJ , Huang J , Rubin MA . 2016a. Neuroendocrine tumours. In WHO classification of tumours of the urinary system and male genital organs (ed. Moch H, ), pp. 172\u2013174. IARC, Lyon, France."},{"key":"2018091410361216000_7.10.a030411.45","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of grading patterns and proposal for a new grading system","volume":"40","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"2018091410361216000_7.10.a030411.46","unstructured":"Epstein JI , Oxley J , Ro JY , Van der Kwast T , Zhou M . 2016c. Intraductal carcinoma. In WHO classification of tumours of the urinary system and male genital organs (ed. Moch H , ), pp. 164\u2013165. IARC, Lyon, France."},{"key":"2018091410361216000_7.10.a030411.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.06.046"},{"key":"2018091410361216000_7.10.a030411.48","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200606000-00003"},{"key":"2018091410361216000_7.10.a030411.49","doi-asserted-by":"crossref","first-page":"233.e1","DOI":"10.1016\/j.urolonc.2015.10.013","article-title":"Validation of lymphovascular invasion is an indepenedent prognostic factor for biochemical recurrence after radical prostatectomy","volume":"34","year":"2016","journal-title":"Urol Oncol"},{"key":"2018091410361216000_7.10.a030411.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2004.06.015"},{"key":"2018091410361216000_7.10.a030411.51","unstructured":"Ferry JA . 2016. Hematolymphoid tumours. In WHO classification of tumours of the urinary system and male genital organs (ed. Moch H, ), p. 178. IARC, Lyon, France."},{"key":"2018091410361216000_7.10.a030411.52","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31828d5c32"},{"key":"2018091410361216000_7.10.a030411.53","first-page":"2447","article-title":"Frequency and location of mitoses in prostatic intraepithelial neoplasia (PIN)","volume":"13","year":"1993","journal-title":"Anticancer Res"},{"key":"2018091410361216000_7.10.a030411.54","first-page":"125","article-title":"Classification of prostate carcinoma","volume":"50","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"2018091410361216000_7.10.a030411.55","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(92)90108-F"},{"key":"2018091410361216000_7.10.a030411.56","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0022-5347(17)59889-4","article-title":"Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging","volume":"111","author":"Veterans Administration Cooperative Urological Research Group","year":"1974","journal-title":"J Urol"},{"key":"2018091410361216000_7.10.a030411.57","unstructured":"Gleason DF ; Veterans Adminstration Cooperative Urological Research Group. 1977. Histologica grading and clinical staging of prostatic carcinoma. In Urologic pathology: The prostate (ed. Tannenbaum M ), pp. 171\u2013197. Lea & Febinger, Philadelphia."},{"key":"2018091410361216000_7.10.a030411.58","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/PAS.0b013e3182495dee","article-title":"Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue","volume":"36","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"2018091410361216000_7.10.a030411.59","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-5347(17)60174-5","article-title":"Primary transitional cell carcinoma of the prostate","volume":"110","year":"1973","journal-title":"J Urol"},{"key":"2018091410361216000_7.10.a030411.60","unstructured":"Grignon DJ . 2016. Urothelial carcinoma. In WHO classification of tumours of the urinary system and male genital organs (ed. Moch H , ), pp. 168\u2013169. IARC, Lyon, France."},{"key":"2018091410361216000_7.10.a030411.61","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800702"},{"key":"2018091410361216000_7.10.a030411.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2010.05.026"},{"key":"2018091410361216000_7.10.a030411.63","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181e6cbf3"},{"key":"2018091410361216000_7.10.a030411.64","doi-asserted-by":"publisher","DOI":"10.1002\/path.4628"},{"key":"2018091410361216000_7.10.a030411.65","first-page":"84","article-title":"Immunohistochemistry in diagnostic surgical pathology of the prostate","volume":"22","year":"2005","journal-title":"Semin Diagn Pathol"},{"key":"2018091410361216000_7.10.a030411.66","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800601"},{"key":"2018091410361216000_7.10.a030411.67","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000209838.92842.bf"},{"key":"2018091410361216000_7.10.a030411.68","doi-asserted-by":"crossref","first-page":"983","DOI":"10.5858\/2009-0277-OA.1","article-title":"Diagnostic utility of P504S\/p63 cocktail, prostate-specific antigen, and prostatic acid phosphatase in verifying prostatic carcinoma involvement in seminal vesicles: A study of 57 cases of radical prostatectomy specimens of pathologic stage pT3b","volume":"134","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"2018091410361216000_7.10.a030411.69","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)00998-5"},{"key":"2018091410361216000_7.10.a030411.70","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00000478-199706000-00014","article-title":"The significance of intraluminal crystalloids in benign prostatic glands on needle biopsy","volume":"21","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"2018091410361216000_7.10.a030411.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2011.09.009"},{"key":"2018091410361216000_7.10.a030411.72","unstructured":"Humphrey PA . 2003a. Unusual prostatic neoplasms. In Prostate pathology (ed. Humphrey PA ), pp. 430\u2013455. ASCP, Chicago."},{"key":"2018091410361216000_7.10.a030411.73","unstructured":"Humphrey PA . 2003b. Prostatic tissue ectopia. In Prostate pathology (ed. Humphrey PA ), pp. 22\u201323. ASCP, Chicago."},{"key":"2018091410361216000_7.10.a030411.74","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2011.04039.x"},{"key":"2018091410361216000_7.10.a030411.75","first-page":"133","article-title":"Corpora amylacea in adenocarcinoma of the prostate: Prevalence in 100 prostatectomies and clinicopathologic correlations","volume":"3","year":"1990","journal-title":"Surg Pathol"},{"key":"2018091410361216000_7.10.a030411.76","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199810000-00009"},{"key":"2018091410361216000_7.10.a030411.77","unstructured":"Humphrey PA , Amin MB , Berney DM , Billis A , Cao D , Cheng L , Delahunt B , Egevad L , Epstein JI , Fine SW , 2016a. Acinar adenocarcinoma. In WHO classification of tumours of the urinary system and male genital organs (ed. Moch H , ), pp. 138\u2013161. IARC, Lyon, France."},{"key":"2018091410361216000_7.10.a030411.78","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014Part B: Prostate and bladder tumours","volume":"70","year":"2016","journal-title":"Eur Urol"},{"key":"2018091410361216000_7.10.a030411.79","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200312000-00004"},{"key":"2018091410361216000_7.10.a030411.80","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/pros.2990010105","article-title":"Prostatic crystalloids: Association with adenocarcinoma","volume":"1","year":"1980","journal-title":"Prostate"},{"key":"2018091410361216000_7.10.a030411.81","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200111000-00007"},{"key":"2018091410361216000_7.10.a030411.82","doi-asserted-by":"publisher","DOI":"10.1309\/1G1NK9DBGFNB792L"},{"key":"2018091410361216000_7.10.a030411.83","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/109.6.695"},{"key":"2018091410361216000_7.10.a030411.84","first-page":"3469","article-title":"Collagenous micronodules in prostate cancer revisited: Are they solely associated with Gleason pattern 3 adenocarcinomas?","volume":"8","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"2018091410361216000_7.10.a030411.85","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ebiom.2016.03.047","article-title":"Tissue effects in a randomized controlled trial of short-term finasteride in early prostate cancer","volume":"7","year":"2016","journal-title":"EBioMedicine"},{"key":"2018091410361216000_7.10.a030411.86","first-page":"68","article-title":"Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens","volume":"74","year":"2014","journal-title":"Prostate"},{"key":"2018091410361216000_7.10.a030411.87","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2014.07.002"},{"key":"2018091410361216000_7.10.a030411.88","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318262c3d0"},{"key":"2018091410361216000_7.10.a030411.89","first-page":"30","article-title":"Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy","volume":"29","year":"2016","journal-title":"Mod Pathol"},{"key":"2018091410361216000_7.10.a030411.90","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2006.04.028"},{"key":"2018091410361216000_7.10.a030411.91","doi-asserted-by":"crossref","first-page":"683","DOI":"10.5858\/2005-129-0683-PGCCOT","article-title":"Pleomorphic giant cell carcinoma of the prostate","volume":"129","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"2018091410361216000_7.10.a030411.92","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.201"},{"key":"2018091410361216000_7.10.a030411.93","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22897"},{"key":"2018091410361216000_7.10.a030411.94","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.158"},{"key":"2018091410361216000_7.10.a030411.95","doi-asserted-by":"publisher","DOI":"10.1038\/pcan.2012.4"},{"key":"2018091410361216000_7.10.a030411.96","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.urology.2015.06.011","article-title":"Sarcomatoid carcinoma of the prostate: Retrospective review of a case series from the Johns Hopkins Hospital","volume":"86","year":"2015","journal-title":"Urology"},{"key":"2018091410361216000_7.10.a030411.97","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199607000-00003"},{"key":"2018091410361216000_7.10.a030411.98","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900915)66:6<1225::AID-CNCR2820660624>3.0.CO;2-X"},{"key":"2018091410361216000_7.10.a030411.99","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0046-8177(91)90006-B","article-title":"Mucinous differentiation in prostatic adenocarcinoma","volume":"22","year":"1991","journal-title":"Hum Pathol"},{"key":"2018091410361216000_7.10.a030411.100","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318206b67b"},{"key":"2018091410361216000_7.10.a030411.101","first-page":"2518","article-title":"Heterogeneous clinicopathologic features of intraductal carcinoma of the prostate: A comparison bewteen \u201cprecursor-like\u201d and \u201cregular-type\u201d lesions","volume":"7","year":"2014","journal-title":"Int J Clin Pathol"},{"key":"2018091410361216000_7.10.a030411.102","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000348"},{"key":"2018091410361216000_7.10.a030411.103","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.2806"},{"key":"2018091410361216000_7.10.a030411.104","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200403000-00014"},{"key":"2018091410361216000_7.10.a030411.105","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/1097-0142(19930201)71:3+<906::AID-CNCR2820711407>3.0.CO;2-I","article-title":"A pathologist\u2019s view of prostatic carcinoma","volume":"71","year":"1993","journal-title":"Cancer"},{"key":"2018091410361216000_7.10.a030411.106","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/pros.23215","article-title":"A novel system for estimating residual disease and pathologic response to neoadjuvant treatment of prostate cancer","volume":"76","year":"2016","journal-title":"Prostate"},{"key":"2018091410361216000_7.10.a030411.107","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2014.21"},{"key":"2018091410361216000_7.10.a030411.108","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199604000-00004"},{"key":"2018091410361216000_7.10.a030411.109","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP8EL5FTZSOBIH"},{"key":"2018091410361216000_7.10.a030411.110","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09539.x"},{"key":"2018091410361216000_7.10.a030411.111","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318157020e"},{"key":"2018091410361216000_7.10.a030411.112","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181589f72"},{"key":"2018091410361216000_7.10.a030411.113","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(98)90073-9"},{"key":"2018091410361216000_7.10.a030411.114","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200004000-00011"},{"key":"2018091410361216000_7.10.a030411.115","doi-asserted-by":"publisher","DOI":"10.1593\/neo.10726"},{"key":"2018091410361216000_7.10.a030411.116","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2014.06.008"},{"key":"2018091410361216000_7.10.a030411.117","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200405000-00014"},{"key":"2018091410361216000_7.10.a030411.118","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000209841.77595.4b"},{"key":"2018091410361216000_7.10.a030411.119","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11611.x"},{"key":"2018091410361216000_7.10.a030411.120","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1994.tb01332.x"},{"key":"2018091410361216000_7.10.a030411.121","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(97)00164-7"},{"key":"2018091410361216000_7.10.a030411.122","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860615)57:12<2397::AID-CNCR2820571226>3.0.CO;2-1"},{"key":"2018091410361216000_7.10.a030411.123","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(96)90004-0"},{"key":"2018091410361216000_7.10.a030411.124","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.06.017"},{"key":"2018091410361216000_7.10.a030411.125","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2011-0519-RA"},{"key":"2018091410361216000_7.10.a030411.126","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.13.1662"},{"key":"2018091410361216000_7.10.a030411.127","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.eururo.2015.10.040","article-title":"Genomic correlates to the newly proposed grading prognostic groups for prostate cancer","volume":"69","year":"2016","journal-title":"Eur Urol"},{"key":"2018091410361216000_7.10.a030411.128","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199611)180:3<295::AID-PATH663>3.0.CO;2-W"},{"key":"2018091410361216000_7.10.a030411.129","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2011-200460"},{"key":"2018091410361216000_7.10.a030411.130","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0000000000000714","article-title":"Interobserver reproducibility of percent Gleason pattern 4 in prostatic adenocarcinoma on prostate biopsies","volume":"40:","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"2018091410361216000_7.10.a030411.131","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(98)00595-0"},{"key":"2018091410361216000_7.10.a030411.132","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/PAT.0000000000000315","article-title":"The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer","volume":"47","year":"2015","journal-title":"Pathology"},{"key":"2018091410361216000_7.10.a030411.133","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/modpathol.2009.103","article-title":"Gene expression profiles of ductal versus acinar adenocarcinoma of the prostate","volume":"22","year":"2009","journal-title":"Mod Pathol"},{"key":"2018091410361216000_7.10.a030411.134","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.eururo.2015.10.029","article-title":"Clinical utility of quantitative Gleason grading in prostate biopsies and prostatectomy specimens","volume":"69","year":"2016","journal-title":"Eur Urol"},{"key":"2018091410361216000_7.10.a030411.135","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2010.03564.x"},{"key":"2018091410361216000_7.10.a030411.136","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2013.05.005"},{"key":"2018091410361216000_7.10.a030411.137","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.pathol.2016.04.001","article-title":"Ductal adenocarcinoma of the prostate: Histogenesis, biology and clinicopathological features","volume":"48","year":"2016","journal-title":"Pathology"},{"key":"2018091410361216000_7.10.a030411.138","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920601)69:11<2676::AID-CNCR2820691109>3.0.CO;2-P"},{"key":"2018091410361216000_7.10.a030411.139","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2006.01.027"},{"key":"2018091410361216000_7.10.a030411.140","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3180536678"},{"key":"2018091410361216000_7.10.a030411.141","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.humpath.2015.02.004","article-title":"Basal cell carcinoma of the prostate is an aggressive tumor with frequent loss of PTEN expression and overexpression of EGFR","volume":"46","year":"2015","journal-title":"Hum Pathol"},{"key":"2018091410361216000_7.10.a030411.142","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000090"},{"key":"2018091410361216000_7.10.a030411.143","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/bju.13488","article-title":"Independent surgical validation of the new prostate cancer grade-grouping system","volume":"118","year":"2016","journal-title":"BJU Int"},{"key":"2018091410361216000_7.10.a030411.144","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/pcan.2016.18","article-title":"Independent validation of the prognostic capacity of the ISUP prostate cancer grade grouping system for radiation treated patients with long-term follow-up","volume":"19","year":"2016","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2018091410361216000_7.10.a030411.145","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2011.04079.x"},{"key":"2018091410361216000_7.10.a030411.146","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.15.1395"},{"key":"2018091410361216000_7.10.a030411.147","first-page":"332","article-title":"\u03b1-Methylacyl-CoA racemase (P504S)\/34\u03b2E12\/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy","volume":"39","year":"2007","journal-title":"Hum Pathol"},{"key":"2018091410361216000_7.10.a030411.148","doi-asserted-by":"publisher","DOI":"10.1309\/H4JX0XEHDAC8YL3P"},{"key":"2018091410361216000_7.10.a030411.149","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/modpathol.2014.115","article-title":"Prostate adenocarcinomas aberrantly expressiong p63 are molecularly distinct from usual-type prostatic adenocarcinomas","volume":"28","year":"2015","journal-title":"Mod Pathol"},{"key":"2018091410361216000_7.10.a030411.150","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318160edaf"},{"key":"2018091410361216000_7.10.a030411.151","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870515)59:10<1803::AID-CNCR2820591019>3.0.CO;2-X"},{"key":"2018091410361216000_7.10.a030411.152","first-page":"543","article-title":"Minimal carcinoma in prostate needle biopsy specimens: Diagnostic features and radical prostatectomy follow-up","volume":"11","year":"1998","journal-title":"Mod Pathol"},{"key":"2018091410361216000_7.10.a030411.153","first-page":"552","article-title":"Prostatic carcinoma with signet ring cells: A clinicopathologic and immunohistochemical analysis of 12 cases, with review of the literature","volume":"11","year":"1998","journal-title":"Mod Pathol"},{"key":"2018091410361216000_7.10.a030411.154","first-page":"131","article-title":"Microscopic differential diagnosis of latent carcinoma of prostate","volume":"55","year":"1953","journal-title":"Arch Pathol"},{"key":"2018091410361216000_7.10.a030411.155","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200105000-00008"},{"key":"2018091410361216000_7.10.a030411.156","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.ejca.2012.02.003","article-title":"Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy","volume":"48","year":"2012","journal-title":"Eur J Cancer"},{"key":"2018091410361216000_7.10.a030411.157","doi-asserted-by":"crossref","first-page":"554","DOI":"10.5858\/2002-126-0554-MCFTDO","article-title":"Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsy specimens. A study of 250 consecutive cases in a routine surgical pathology practice","volume":"126","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"2018091410361216000_7.10.a030411.158","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318058a96b"},{"key":"2018091410361216000_7.10.a030411.159","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0463"},{"key":"2018091410361216000_7.10.a030411.160","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/PAS.0b013e318293d85b","article-title":"Foamy gland carcinoma of the prostate in needle biopsy: Incidence, Gleason grade, and comparative \u03b1-methylacyl-CoA racemase versus ERG expression","volume":"37","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"2018091410361216000_7.10.a030411.161","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/his.12198","article-title":"Incidence and clinicopathologic characteristics of intraductal carcinoma detected in prostate biopsies: A prospective cohort study","volume":"63","year":"2013","journal-title":"Histopathology"},{"key":"2018091410361216000_7.10.a030411.162","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1097\/PAS.0000000000000609","article-title":"Differential diagnosis of intraductal lesions of the prostate","volume":"40","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"2018091410361216000_7.10.a030411.163","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200008000-00001"},{"key":"2018091410361216000_7.10.a030411.164","first-page":"1677","article-title":"Identification of differentially expressed genes in human prostate cancer using subtraction and microarray","volume":"60","year":"2000","journal-title":"Cancer Res"},{"key":"2018091410361216000_7.10.a030411.165","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0046-8177(98)90014-4","article-title":"Distinction of basaloid carcinoma of the prostate from benign basal cell lesions by using immunohistochemistry for bcl-2 and Ki-67","volume":"29","year":"1998","journal-title":"Hum Pathol"},{"key":"2018091410361216000_7.10.a030411.166","first-page":"705","article-title":"Small cell carcinoma of the prostate: An immunohistochemical study","volume":"20","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"2018091410361216000_7.10.a030411.167","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PAS.0b013e3181d2a549","article-title":"Microcystic adenocarcinoma of the prostate: A variant of pseudohyperplastic and atrophic patterns","volume":"34","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"2018091410361216000_7.10.a030411.168","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200303000-00010"},{"key":"2018091410361216000_7.10.a030411.169","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200306000-00007"}],"container-title":["Cold Spring Harbor Perspectives in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/cshperspect.a030411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T09:43:20Z","timestamp":1719135800000},"score":1,"resource":{"primary":{"URL":"http:\/\/perspectivesinmedicine.cshlp.org\/lookup\/doi\/10.1101\/cshperspect.a030411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":169,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,3]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1101\/cshperspect.a030411"],"URL":"https:\/\/doi.org\/10.1101\/cshperspect.a030411","relation":{},"ISSN":["2157-1422"],"issn-type":[{"value":"2157-1422","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,7]]}}}